FR2762213B1 - Composition pharmaceutique a retention gastrique - Google Patents
Composition pharmaceutique a retention gastriqueInfo
- Publication number
- FR2762213B1 FR2762213B1 FR9704803A FR9704803A FR2762213B1 FR 2762213 B1 FR2762213 B1 FR 2762213B1 FR 9704803 A FR9704803 A FR 9704803A FR 9704803 A FR9704803 A FR 9704803A FR 2762213 B1 FR2762213 B1 FR 2762213B1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical composition
- gastric retention
- gastric
- retention
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Physiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704803A FR2762213B1 (fr) | 1997-04-18 | 1997-04-18 | Composition pharmaceutique a retention gastrique |
HU0002455A HUP0002455A3 (en) | 1997-04-18 | 1998-04-15 | Gastric-retained pharmaceutical composition |
CA002286081A CA2286081A1 (fr) | 1997-04-18 | 1998-04-15 | Composition pharmaceutique a residence gastrique |
NZ500288A NZ500288A (en) | 1997-04-18 | 1998-04-15 | Gastric-retained pharmaceutical composition comprising benzamide as the active principle and a carbon dioxide generating system |
CN98804269A CN1252720A (zh) | 1997-04-18 | 1998-04-15 | 胃停留药物组合物 |
EP98920623A EP0983065A1 (fr) | 1997-04-18 | 1998-04-15 | Composition pharmaceutique a residence gastrique |
AU73416/98A AU737634B2 (en) | 1997-04-18 | 1998-04-15 | Pharmaceutical composition for gastric residence |
PCT/FR1998/000755 WO1998047506A1 (fr) | 1997-04-18 | 1998-04-15 | Composition pharmaceutique a residence gastrique |
PL98336273A PL336273A1 (en) | 1997-04-18 | 1998-04-15 | Pharmaceutic composition active in stomach portion of gastrointestinal system |
IL13199598A IL131995A0 (en) | 1997-04-18 | 1998-04-15 | Gastric-retained pharmaceutical compositions |
KR1019997009438A KR20010006353A (ko) | 1997-04-18 | 1998-04-15 | 위 체류 약제조성물 |
JP54514398A JP2001523241A (ja) | 1997-04-18 | 1998-04-15 | 胃滞留性医薬組成物 |
TNTNSN98049A TNSN98049A1 (fr) | 1997-04-18 | 1998-04-16 | Composition pharmaceutique a residence gastrique. |
MA25037A MA26482A1 (fr) | 1997-04-18 | 1998-04-17 | Composition pharmaceutique a residence gastrique. |
ARP980101773A AR015586A1 (es) | 1997-04-18 | 1998-04-17 | Composicion farmaceutica de residencia gastrica. |
ZA983258A ZA983258B (en) | 1997-04-18 | 1998-04-17 | Pharmaceutical composition for gastric residence |
PE1998000281A PE68199A1 (es) | 1997-04-18 | 1998-04-17 | Composicion farmaceutica de residencia gastrica |
JO19982017A JO2017B1 (en) | 1997-04-18 | 1998-04-18 | Pharmaceutical formula for infectious residence |
NO995039A NO995039L (no) | 1997-04-18 | 1999-10-15 | Gastrisk bibeholdt farmasoeytisk preparat |
US09/886,991 US20010046473A1 (en) | 1997-04-18 | 2001-06-25 | Gastric-retained pharmaceutical composition and method for its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704803A FR2762213B1 (fr) | 1997-04-18 | 1997-04-18 | Composition pharmaceutique a retention gastrique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2762213A1 FR2762213A1 (fr) | 1998-10-23 |
FR2762213B1 true FR2762213B1 (fr) | 1999-05-14 |
Family
ID=9506077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9704803A Expired - Fee Related FR2762213B1 (fr) | 1997-04-18 | 1997-04-18 | Composition pharmaceutique a retention gastrique |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0983065A1 (fr) |
JP (1) | JP2001523241A (fr) |
KR (1) | KR20010006353A (fr) |
CN (1) | CN1252720A (fr) |
AR (1) | AR015586A1 (fr) |
AU (1) | AU737634B2 (fr) |
CA (1) | CA2286081A1 (fr) |
FR (1) | FR2762213B1 (fr) |
HU (1) | HUP0002455A3 (fr) |
IL (1) | IL131995A0 (fr) |
JO (1) | JO2017B1 (fr) |
MA (1) | MA26482A1 (fr) |
NO (1) | NO995039L (fr) |
NZ (1) | NZ500288A (fr) |
PE (1) | PE68199A1 (fr) |
PL (1) | PL336273A1 (fr) |
TN (1) | TNSN98049A1 (fr) |
WO (1) | WO1998047506A1 (fr) |
ZA (1) | ZA983258B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
FR2784583B1 (fr) | 1998-10-16 | 2002-01-25 | Synthelabo | Composition pharmaceutique a residence gastrique et a liberation controlee |
FR2790388B1 (fr) * | 1999-03-04 | 2001-04-13 | Synthelabo | Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption |
EP1245227A1 (fr) | 2001-03-31 | 2002-10-02 | Jagotec Ag | Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé |
WO2009157711A2 (fr) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | Comprimé poreux gastro-rétentif et son procédé de préparation |
FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
PT2719376E (pt) * | 2012-10-12 | 2015-07-06 | Omya Int Ag | Sistemas de formulação e ministração de medicamentos gastrorretentivos e o seu método de preparação usando carbonato de cálcio funcionalizado |
CN112236138B (zh) | 2017-12-05 | 2024-05-31 | 赛诺维信制药公司 | 晶体形式及其制备方法 |
CA3084953A1 (fr) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Melanges non racemiques et leurs utilisations |
JP7044649B2 (ja) * | 2018-06-28 | 2022-03-30 | 株式会社ファンケル | 胃内浮遊錠剤 |
SG11202113266YA (en) | 2019-06-04 | 2021-12-30 | Sunovion Pharmaceuticals Inc | Modified release formulations and uses thereof |
WO2023214018A1 (fr) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Composition à libération prolongée gonflable à rétention gastrique |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2415099A1 (fr) * | 1978-01-20 | 1979-08-17 | Ile De France | Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes |
FR2554718B1 (fr) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
JPS62178518A (ja) * | 1986-01-30 | 1987-08-05 | Toho Yakuhin Kogyo Kk | 新規持続性スルピリド錠剤 |
JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
CA2039742A1 (fr) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Comprimes pour ingredients pharmaceutiques sujets a problemes : composition et mode de preparation |
-
1997
- 1997-04-18 FR FR9704803A patent/FR2762213B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-15 KR KR1019997009438A patent/KR20010006353A/ko not_active Application Discontinuation
- 1998-04-15 CN CN98804269A patent/CN1252720A/zh active Pending
- 1998-04-15 WO PCT/FR1998/000755 patent/WO1998047506A1/fr not_active Application Discontinuation
- 1998-04-15 EP EP98920623A patent/EP0983065A1/fr not_active Ceased
- 1998-04-15 AU AU73416/98A patent/AU737634B2/en not_active Ceased
- 1998-04-15 PL PL98336273A patent/PL336273A1/xx unknown
- 1998-04-15 NZ NZ500288A patent/NZ500288A/xx unknown
- 1998-04-15 CA CA002286081A patent/CA2286081A1/fr not_active Abandoned
- 1998-04-15 HU HU0002455A patent/HUP0002455A3/hu unknown
- 1998-04-15 IL IL13199598A patent/IL131995A0/xx unknown
- 1998-04-15 JP JP54514398A patent/JP2001523241A/ja active Pending
- 1998-04-16 TN TNTNSN98049A patent/TNSN98049A1/fr unknown
- 1998-04-17 MA MA25037A patent/MA26482A1/fr unknown
- 1998-04-17 PE PE1998000281A patent/PE68199A1/es not_active Application Discontinuation
- 1998-04-17 AR ARP980101773A patent/AR015586A1/es unknown
- 1998-04-17 ZA ZA983258A patent/ZA983258B/xx unknown
- 1998-04-18 JO JO19982017A patent/JO2017B1/en active
-
1999
- 1999-10-15 NO NO995039A patent/NO995039L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0002455A3 (en) | 2001-01-29 |
IL131995A0 (en) | 2001-03-19 |
FR2762213A1 (fr) | 1998-10-23 |
NO995039D0 (no) | 1999-10-15 |
AR015586A1 (es) | 2001-05-16 |
TNSN98049A1 (fr) | 2005-03-15 |
NZ500288A (en) | 2001-03-30 |
PE68199A1 (es) | 1999-07-15 |
KR20010006353A (ko) | 2001-01-26 |
MA26482A1 (fr) | 2004-12-20 |
NO995039L (no) | 1999-12-17 |
JO2017B1 (en) | 1999-05-15 |
ZA983258B (en) | 1998-10-19 |
WO1998047506A1 (fr) | 1998-10-29 |
CN1252720A (zh) | 2000-05-10 |
JP2001523241A (ja) | 2001-11-20 |
AU737634B2 (en) | 2001-08-23 |
AU7341698A (en) | 1998-11-13 |
EP0983065A1 (fr) | 2000-03-08 |
HUP0002455A2 (hu) | 2000-12-28 |
CA2286081A1 (fr) | 1998-10-29 |
PL336273A1 (en) | 2000-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4974A (is) | Lyfjasamsetning á þrýstingsúðaformi | |
EE200000098A (et) | Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks | |
ID23874A (id) | Obat | |
DK0783302T3 (da) | Lægemidler | |
FI973243A0 (fi) | Uusi farmaseuttinen yhdistelmä | |
NO20021172L (no) | Farmasöytisk sammensetning | |
FI955311A0 (fi) | Farmaseuttinen koostumuspohja | |
NO994003L (no) | Farmasoytisk blanding | |
DK1017392T3 (da) | Lægemiddel | |
FR2762213B1 (fr) | Composition pharmaceutique a retention gastrique | |
EE9900545A (et) | Farmatseutiline kompositsioon | |
BR9600809A (pt) | Medicamento | |
ID29294A (id) | Komposisi farmasi | |
LV11727A (lv) | Farmaceitiska kompozicija | |
MA26531A1 (fr) | Composition pharmaceutique | |
ID25857A (id) | Komposisi farmasi | |
FI955605A0 (fi) | Aryloivia lääkkeitä | |
BR9605777A (pt) | Composição farmacêutica | |
ID23531A (id) | Komposisi farmasi | |
BR9605131A (pt) | Composição farmacêutica | |
FR2772264B1 (fr) | Pilulier | |
BR1100755A (pt) | composição farmacêutica | |
ID21180A (id) | Senyawa-senyawa farmasi | |
FI3163U1 (fi) | Lääkesäiliö | |
FI3862U1 (fi) | Geelimuotoinen farmaseuttinen valmiste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
ST | Notification of lapse |